The American Association of Neurological Surgeons (AANS), with support from Brainlab, has developed a national prospective Stereotactic Radiosurgery Registry (SRS). Stereotactic radiosurgery is a minimally invasive approach using imaging guidance and stereotactic principles to deliver radiation to targeted cells within the body. It has become an important part of the treatment of brain metastases, benign brain tumors and arteriovenous malformations (AVMs). The registry is comprised of over 20 national, high-volume sites that collect patient reported outcomes at routine intervals (three to six months after SRS). NeuroPoint Alliance oversees registry management, and Brainlab provides the registry’s technology platform and related support.
The registry is aimed at providing national benchmarks for SRS treatments to provide clinicians and patients the data required to make informed treatment decisions. The registry objectives are to:
- Define national patterns of care in radiosurgery
- Improve healthcare outcomes and support informed decision-making
- Explore the potential to lower the cost of care delivery to patients
Registry information is used to help pinpoint more effective treatments for conditions affecting certain patient populations. The SRS registry is currently closed to new centers.
For questions on the SRS registry or for more information, contact NPA.